ES447114A1 - Nuevo procedimiento para la preparacion de derivados con en-lace peptidico. - Google Patents

Nuevo procedimiento para la preparacion de derivados con en-lace peptidico.

Info

Publication number
ES447114A1
ES447114A1 ES447114A ES447114A ES447114A1 ES 447114 A1 ES447114 A1 ES 447114A1 ES 447114 A ES447114 A ES 447114A ES 447114 A ES447114 A ES 447114A ES 447114 A1 ES447114 A1 ES 447114A1
Authority
ES
Spain
Prior art keywords
rho
see formula
acid derivatives
isobutyric acid
chlorophenoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES447114A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Investigacion Tecnica y Aplicada SA
Original Assignee
Investigacion Tecnica y Aplicada SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Investigacion Tecnica y Aplicada SA filed Critical Investigacion Tecnica y Aplicada SA
Priority to ES447114A priority Critical patent/ES447114A1/es
Priority to JP254077A priority patent/JPS52128383A/ja
Priority to GB15327/77A priority patent/GB1535683A/en
Priority to DE2716374A priority patent/DE2716374C2/de
Priority to FR7711801A priority patent/FR2348207A1/fr
Publication of ES447114A1 publication Critical patent/ES447114A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
ES447114A 1976-04-15 1976-04-15 Nuevo procedimiento para la preparacion de derivados con en-lace peptidico. Expired ES447114A1 (es)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ES447114A ES447114A1 (es) 1976-04-15 1976-04-15 Nuevo procedimiento para la preparacion de derivados con en-lace peptidico.
JP254077A JPS52128383A (en) 1976-04-15 1977-01-14 Method of producing ppchlorophenoxy isobutyric acid derivative
GB15327/77A GB1535683A (en) 1976-04-15 1977-04-13 Rho-chlorophenoxy isobutyric acid derivatives
DE2716374A DE2716374C2 (de) 1976-04-15 1977-04-13 N-2-(p-Chlorphenoxy)-isobutyryl-N'-morpholinmethylharnstoff, dessen Salze, Verfahren zu deren Herstellung und pharmazeutische Zubereitung
FR7711801A FR2348207A1 (fr) 1976-04-15 1977-04-14 Derive a liaison peptidique utilisable en medecine humaine et son procede de preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES447114A ES447114A1 (es) 1976-04-15 1976-04-15 Nuevo procedimiento para la preparacion de derivados con en-lace peptidico.

Publications (1)

Publication Number Publication Date
ES447114A1 true ES447114A1 (es) 1977-11-01

Family

ID=8471384

Family Applications (1)

Application Number Title Priority Date Filing Date
ES447114A Expired ES447114A1 (es) 1976-04-15 1976-04-15 Nuevo procedimiento para la preparacion de derivados con en-lace peptidico.

Country Status (5)

Country Link
JP (1) JPS52128383A (cg-RX-API-DMAC7.html)
DE (1) DE2716374C2 (cg-RX-API-DMAC7.html)
ES (1) ES447114A1 (cg-RX-API-DMAC7.html)
FR (1) FR2348207A1 (cg-RX-API-DMAC7.html)
GB (1) GB1535683A (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES472295A1 (es) * 1978-08-02 1979-02-16 Invest Tecnica Aplicada Procedimiento de obtencion de nuevas acilureas con actividadfarmacologica
CA2052014A1 (en) * 1990-10-19 1992-04-20 Henry Y. Pan Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1296513B (de) * 1965-12-30 1969-05-29 Adox Du Pont Fotowerke Verfahren zum Haerten von gelatinehaltigen photographischen Schichten, insbesondere Halogensilberemulsionsschichten
US3927092A (en) * 1968-06-24 1975-12-16 Merck & Co Inc Amides of 2-{8 halophenoxy (or halophenylthio){9 -alkanoic acids
DE1936282A1 (de) * 1969-07-17 1971-01-28 Ruhrchemie Ag Verfahren zur Herstellung von N,N'-disubstituierten Harnstoffen und Thioharnstoffen
FR2187311B1 (cg-RX-API-DMAC7.html) * 1972-06-02 1975-06-20 Bouchara Emile

Also Published As

Publication number Publication date
DE2716374C2 (de) 1986-09-25
FR2348207B1 (cg-RX-API-DMAC7.html) 1980-02-08
FR2348207A1 (fr) 1977-11-10
GB1535683A (en) 1978-12-13
DE2716374A1 (de) 1977-11-03
JPS52128383A (en) 1977-10-27

Similar Documents

Publication Publication Date Title
SE8202034L (sv) Nytt kemiskt forfarande for framstellning av propionitrilderivat
ES404328A1 (es) Un procedimiento para la preparacion de delta3-tiazolinas.
ES447114A1 (es) Nuevo procedimiento para la preparacion de derivados con en-lace peptidico.
JPS51136622A (en) Process for preparation of isocyanic acid derivatives
ES400820A1 (es) Procedimiento para preparar 3-amino-imidazo (1,5-a) piridi-nas.
MY102732A (en) A process for the manufacture of n, n-(dibenzohexatrienylene) ureas
ES445906A1 (es) Procedimiento para la preparacion de tioamidas.
ES454228A1 (es) Procedimiento para la sintesis de n-metil ureas.
ES462849A1 (es) Un procedimiento para la preparacion de nuevos derivados de 3,5-diona-4,4-dimetil-pirrolidina.
ES462844A1 (es) Un procedimiento para la preparacion de compuestos imidazo (1,5-a) (1,4)diacepinicos.
ES436868A1 (es) Procedimiento de preparacion de clorhidrato de la n-nicoti-noil-o-para-clorofenoxi-isobutanoil-etanol-amina.
ES450129A1 (es) Procedimiento para la preparacion de fluorhidrato de 3-piri-dil-metanol.
SU554867A1 (ru) Способ получени диагностики дл проведени серологических реакций
ES457708A1 (es) Un procedimiento para la preparacion de un compuesto de 3- hidroximetil-2-cefem.
ES437774A1 (es) Procedimiento para la preparacion de fumarato de espasmio.
ES431414A1 (es) Procedimiento de obtencion de 5, 11-dioxo-5, 6, 11, 12-te- trahidro-dibenzo (b, f) (1,5) oxozocina.
ES435898A1 (es) Un procedimiento de preparacion de clofibrato de metformi- na.
ES307939A1 (es) Procedimiento para la obtencion de derivados heterociclicos de urea sulfonica.
ES386483A1 (es) Procedimiento para la obtencion de colorantes azoicos.
ES8505513A1 (es) Procedimiento para la fabricacion de aminoacetonitrilos.
JPS51143618A (en) A process for preparing novel nitroso compounds
ES387921A1 (es) Un procedimiento para la preparacion de derivados de dife- niltetrafluoretano.
ES432523A1 (es) Procedimiento de obtencion de nuevas sales organicas de bismuto.
ES442804A1 (es) Un procedimiento para preparar una composicion de dialquil- p-fenilendiaminas simetricas y asimetricas.
ES462359A1 (es) Procedimiento para la obtencion de 9 alfa-cloro-11-beta-flo-resteroides.